Lilly Singapore Centre for Drug Discovery Eli Lilly and Company is a leading, innovation-driven pharmaceutical corporation with a firm commitment to help people live longer, healthier and more active lives by making breakthroughs in medicines and treatments.
To find the next generation of drugs, we know we need to use next generation technologies and employ the best of the biopharmaceutical industry.
The Integrative Computational Sciences (ICS) group at Lilly Singapore Centre for Drug Discovery (LSCDD), provides state-of-the-art computational solutions to enable the global efforts of drug discovery, translational medicine and tailored therapeutics at the post genomic era.
As an ICS team member, via the development of cutting-edge tools, you will have a global impact on the future of personalized medicine: ‘The Right Drug, at The Right Dose for The Right Patient at The Right Time’! |